Report Detail
Global Low Molecular Weight Heparin (LMWHs) Market Insights, Forecast to 2025
- RnM2644515 |
- 20 March, 2019 |
- Global |
- 119 Pages |
- QYResearch |
- Pharma & Healthcare
The global Low Molecular Weight Heparin (LMWHs) market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Low Molecular Weight Heparin (LMWHs) market based on company, product type, end user and key regions.
This report studies the global market size of Low Molecular Weight Heparin (LMWHs) in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Low Molecular Weight Heparin (LMWHs) in these regions.
This research report categorizes the global Low Molecular Weight Heparin (LMWHs) market by top players/brands, region, type and end user. This report also studies the global Low Molecular Weight Heparin (LMWHs) market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Aspen
Sanofi-aventis
Pfizer
Opocrin
CSBIO
Dongying Tiandong Pharmaceutical
Changzhou Qianhong Bio-pharma
Techdow
Yantai Dongcheng Pharmaceutical Group
Market size by Product
Enoxaparin
Dalteparin
Tinzaparin
Fraxiparine
Market size by End User
Treatment of Venous Thromboembolism
Complications of Pregnancy
Cardioversion of Atrial Fibrillation/Flutter
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Low Molecular Weight Heparin (LMWHs) market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Low Molecular Weight Heparin (LMWHs) market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Low Molecular Weight Heparin (LMWHs) companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Low Molecular Weight Heparin (LMWHs) submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Low Molecular Weight Heparin (LMWHs) are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Low Molecular Weight Heparin (LMWHs) market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Low Molecular Weight Heparin (LMWHs) Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Low Molecular Weight Heparin (LMWHs) Market Size Growth Rate by Product
- 1.4.2 Enoxaparin
- 1.4.3 Dalteparin
- 1.4.4 Tinzaparin
- 1.4.5 Fraxiparine
- 1.5 Market by End User
- 1.5.1 Global Low Molecular Weight Heparin (LMWHs) Market Size Growth Rate by End User
- 1.5.2 Treatment of Venous Thromboembolism
- 1.5.3 Complications of Pregnancy
- 1.5.4 Cardioversion of Atrial Fibrillation/Flutter
- 1.5.5 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Low Molecular Weight Heparin (LMWHs) Market Size
- 2.1.1 Global Low Molecular Weight Heparin (LMWHs) Revenue 2014-2025
- 2.1.2 Global Low Molecular Weight Heparin (LMWHs) Sales 2014-2025
- 2.2 Low Molecular Weight Heparin (LMWHs) Growth Rate by Regions
- 2.2.1 Global Low Molecular Weight Heparin (LMWHs) Sales by Regions
- 2.2.2 Global Low Molecular Weight Heparin (LMWHs) Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Low Molecular Weight Heparin (LMWHs) Sales by Manufacturers
- 3.1.1 Low Molecular Weight Heparin (LMWHs) Sales by Manufacturers
- 3.1.2 Low Molecular Weight Heparin (LMWHs) Sales Market Share by Manufacturers
- 3.1.3 Global Low Molecular Weight Heparin (LMWHs) Market Concentration Ratio (CR5 and HHI)
- 3.2 Low Molecular Weight Heparin (LMWHs) Revenue by Manufacturers
- 3.2.1 Low Molecular Weight Heparin (LMWHs) Revenue by Manufacturers (2014-2019)
- 3.2.2 Low Molecular Weight Heparin (LMWHs) Revenue Share by Manufacturers (2014-2019)
- 3.3 Low Molecular Weight Heparin (LMWHs) Price by Manufacturers
- 3.4 Low Molecular Weight Heparin (LMWHs) Manufacturing Base Distribution, Product Types
- 3.4.1 Low Molecular Weight Heparin (LMWHs) Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Low Molecular Weight Heparin (LMWHs) Product Type
- 3.4.3 Date of International Manufacturers Enter into Low Molecular Weight Heparin (LMWHs) Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Low Molecular Weight Heparin (LMWHs) Sales by Product
- 4.2 Global Low Molecular Weight Heparin (LMWHs) Revenue by Product
- 4.3 Low Molecular Weight Heparin (LMWHs) Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Low Molecular Weight Heparin (LMWHs) Breakdown Data by End User
6 North America
- 6.1 North America Low Molecular Weight Heparin (LMWHs) by Countries
- 6.1.1 North America Low Molecular Weight Heparin (LMWHs) Sales by Countries
- 6.1.2 North America Low Molecular Weight Heparin (LMWHs) Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Low Molecular Weight Heparin (LMWHs) by Product
- 6.3 North America Low Molecular Weight Heparin (LMWHs) by End User
7 Europe
- 7.1 Europe Low Molecular Weight Heparin (LMWHs) by Countries
- 7.1.1 Europe Low Molecular Weight Heparin (LMWHs) Sales by Countries
- 7.1.2 Europe Low Molecular Weight Heparin (LMWHs) Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Low Molecular Weight Heparin (LMWHs) by Product
- 7.3 Europe Low Molecular Weight Heparin (LMWHs) by End User
8 Asia Pacific
- 8.1 Asia Pacific Low Molecular Weight Heparin (LMWHs) by Countries
- 8.1.1 Asia Pacific Low Molecular Weight Heparin (LMWHs) Sales by Countries
- 8.1.2 Asia Pacific Low Molecular Weight Heparin (LMWHs) Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Low Molecular Weight Heparin (LMWHs) by Product
- 8.3 Asia Pacific Low Molecular Weight Heparin (LMWHs) by End User
9 Central & South America
- 9.1 Central & South America Low Molecular Weight Heparin (LMWHs) by Countries
- 9.1.1 Central & South America Low Molecular Weight Heparin (LMWHs) Sales by Countries
- 9.1.2 Central & South America Low Molecular Weight Heparin (LMWHs) Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Low Molecular Weight Heparin (LMWHs) by Product
- 9.3 Central & South America Low Molecular Weight Heparin (LMWHs) by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Low Molecular Weight Heparin (LMWHs) by Countries
- 10.1.1 Middle East and Africa Low Molecular Weight Heparin (LMWHs) Sales by Countries
- 10.1.2 Middle East and Africa Low Molecular Weight Heparin (LMWHs) Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Low Molecular Weight Heparin (LMWHs) by Product
- 10.3 Middle East and Africa Low Molecular Weight Heparin (LMWHs) by End User
11 Company Profiles
- 11.1 Aspen
- 11.1.1 Aspen Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Aspen Low Molecular Weight Heparin (LMWHs) Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Aspen Low Molecular Weight Heparin (LMWHs) Products Offered
- 11.1.5 Aspen Recent Development
- 11.2 Sanofi-aventis
- 11.2.1 Sanofi-aventis Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Sanofi-aventis Low Molecular Weight Heparin (LMWHs) Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Sanofi-aventis Low Molecular Weight Heparin (LMWHs) Products Offered
- 11.2.5 Sanofi-aventis Recent Development
- 11.3 Pfizer
- 11.3.1 Pfizer Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Pfizer Low Molecular Weight Heparin (LMWHs) Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Pfizer Low Molecular Weight Heparin (LMWHs) Products Offered
- 11.3.5 Pfizer Recent Development
- 11.4 Opocrin
- 11.4.1 Opocrin Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Opocrin Low Molecular Weight Heparin (LMWHs) Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Opocrin Low Molecular Weight Heparin (LMWHs) Products Offered
- 11.4.5 Opocrin Recent Development
- 11.5 CSBIO
- 11.5.1 CSBIO Company Details
- 11.5.2 Company Business Overview
- 11.5.3 CSBIO Low Molecular Weight Heparin (LMWHs) Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 CSBIO Low Molecular Weight Heparin (LMWHs) Products Offered
- 11.5.5 CSBIO Recent Development
- 11.6 Dongying Tiandong Pharmaceutical
- 11.6.1 Dongying Tiandong Pharmaceutical Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin (LMWHs) Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin (LMWHs) Products Offered
- 11.6.5 Dongying Tiandong Pharmaceutical Recent Development
- 11.7 Changzhou Qianhong Bio-pharma
- 11.7.1 Changzhou Qianhong Bio-pharma Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin (LMWHs) Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin (LMWHs) Products Offered
- 11.7.5 Changzhou Qianhong Bio-pharma Recent Development
- 11.8 Techdow
- 11.8.1 Techdow Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Techdow Low Molecular Weight Heparin (LMWHs) Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Techdow Low Molecular Weight Heparin (LMWHs) Products Offered
- 11.8.5 Techdow Recent Development
- 11.9 Yantai Dongcheng Pharmaceutical Group
- 11.9.1 Yantai Dongcheng Pharmaceutical Group Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin (LMWHs) Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin (LMWHs) Products Offered
- 11.9.5 Yantai Dongcheng Pharmaceutical Group Recent Development
12 Future Forecast
- 12.1 Low Molecular Weight Heparin (LMWHs) Market Forecast by Regions
- 12.1.1 Global Low Molecular Weight Heparin (LMWHs) Sales Forecast by Regions 2019-2025
- 12.1.2 Global Low Molecular Weight Heparin (LMWHs) Revenue Forecast by Regions 2019-2025
- 12.2 Low Molecular Weight Heparin (LMWHs) Market Forecast by Product
- 12.2.1 Global Low Molecular Weight Heparin (LMWHs) Sales Forecast by Product 2019-2025
- 12.2.2 Global Low Molecular Weight Heparin (LMWHs) Revenue Forecast by Product 2019-2025
- 12.3 Low Molecular Weight Heparin (LMWHs) Market Forecast by End User
- 12.4 North America Low Molecular Weight Heparin (LMWHs) Forecast
- 12.5 Europe Low Molecular Weight Heparin (LMWHs) Forecast
- 12.6 Asia Pacific Low Molecular Weight Heparin (LMWHs) Forecast
- 12.7 Central & South America Low Molecular Weight Heparin (LMWHs) Forecast
- 12.8 Middle East and Africa Low Molecular Weight Heparin (LMWHs) Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Low Molecular Weight Heparin (LMWHs) Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Low Molecular Weight Heparin (LMWHs) . Industry analysis & Market Report on Low Molecular Weight Heparin (LMWHs) is a syndicated market report, published as Global Low Molecular Weight Heparin (LMWHs) Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Low Molecular Weight Heparin (LMWHs) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
